bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.05.02.539089

Biomolecular Condensates defined by Receptor Independent Activator of G protein Signaling: Properties and Regulation

Abstract

Activator of G-protein Signaling 3 (AGS3), a receptor independent activator of G-protein signaling, oscillates among different subcellular compartments in a regulated manner including punctate entities referred to as biomolecular condensates (BMCs). The dynamics of the AGS3 oscillation and the specific subcompartment within the cell is intimately related to the functional diversity of the protein. To further address the properties and regulation of AGS3 BMCs, we asked initial questions regarding a) the distribution of AGS3 across the broader BMC landscape with and without cellular stress, and b) the core material properties of these punctate structures. Cellular stress (oxidative, pHi, thermal) induced the formation of AGS3 BMCs in two cell lines (Hela, COS7) as determined by fluorescent microscopy. The AGS3-BMCs generated in response to oxidative stress were distinct from stress granules (SG) as defined by the SG marker protein G3BP1 and RNA processing BMCs defined by the P-body protein Dcp1a. Immunoblots of fractionated cell lysates indicated that cellular stress shifted AGS3 to the membrane pellet fraction, whereas the protein markers for stress granules (G3BP1) SG- BMCs remained in the supernatant. We next asked if the formation of the stress-induced AGS3 BMCs was regulated by protein binding partners involved with signal processing. The stress-induced generation of AGS3 BMCs was regulated by the signaling protein Gi3, but not by the AGS3 binding partner DVL2. Finally, we addressed the fluidity or rigidity of the stress-induced AGS3-BMCs using fluorescent recovery following photobleaching of individual AGS3-BMCs. The AGS3-BMCs indicated distinct diffusion kinetics that were consistent with restricted mobility of AGS3 within the stress-induced AGS3-BMCs. These data suggest that AGS3 BMCs represents a distinct class of stress granules that define a new type of BMC that may serve as previously unappreciated signal processing nodes. Summary statementAGS3 assembles into distinct biomolecular condensates in response to cell stress and this assembly is selectively regulated by AGS3 binding partners involved in signal transduction within the cell.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vural, A., Lanier, S. M.. 2023-05-03. Biomolecular Condensates defined by Receptor Independent Activator of G protein Signaling: Properties and Regulation. https://doi.org/10.1101/2023.05.02.539089

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Nucleosome Core Allostery Governs Chromatin Recognition and Cell Fate

Nucleosomes regulate chromatin folding, accessibility, and factor recruitment. Current models primarily attribute these functions to histone tail modifications, while the core is largely viewed as a structural scaffold. Yet subtle changes within the nucleosome core can produce profound functional consequences, and the mechanisms underlying these effects remain unclear. Here, we describe nucleosome core allostery as a fundamental principle of chromatin regulation that amplifies the impact of minimal nucleosome variations. Leveraging natural differences between H2A.Z variants, we show that the nucleosome core encodes distinct conformational dynamics that propagate allosterically, thereby controlling nucleosome accessibility and recognition by chromatin factors. As a result, a single buried amino acid substitution alone is sufficient to reprogram nucleosome dynamics and bias cell identity. Our findings establish the nucleosome core as an allosteric regulatory module and provide a generalizable framework for how subtle variation within nucleosomes is amplified into diverse biological outcomes in development and disease.

cell biology↗

SOX4 Reprograms Adipose Stromal Cells into a Cancer-Associated Fibroblast-like State to Drive Metabolic Disease

Pathogenic adipose tissue remodeling promotes metabolic disease in obesity, but the mechanisms that establish this unhealthy tissue state remain poorly understood. Here, we show that obesity drives SOX4-dependent reprogramming of mesenchymal stromal cells (MSCs) into cancer-associated fibroblast-like (CAF-like) cells that promote adipose tissue dysfunction. TGF{beta} signaling is elevated in obesity and activates SOX4 in mouse and human MSCs, inducing their conversion to a CAF-like state. In mice, MSC-specific SOX4 activation induces the CAF-like program and exacerbates adipose tissue inflammation and glucose intolerance, whereas Sox4 deletion attenuates inflammation and improves glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector produced by CAF-like cells. MDK inhibition in obese mice reduces adipose tissue inflammation and improves metabolic function. Together, these findings define a TGF{beta}-SOX4-MDK stromal signaling axis that drives pathological adipose tissue remodeling in obesity and highlight this pathway as a potential therapeutic target for improving metabolic health.

cell biology↗

PDLIM5 Modulates YAP1 Localisation and Fibrogenic Gene Expression in Hepatic Stellate Cells

Hepatic stellate cells (HSCs) are the key cellular drivers of liver fibrosis. During liver injury and chronic inflammation HSCs adopt an activated phenotype and secrete fibrotic extracellular matrix (ECM) components such as collagen 1. Mechanical cues derived from the fibrotic ECM drive and support the activation of HSCs, via mechanisms that involve integrins and the mechano-sensitive transcriptional regulator YAP1. It is not yet well understood how external mechanical cues are translated into a molecular response that alters YAP1 nuclear shuttling. There is evidence that suggests the PDZ and LIM domain protein (PDLIM) 5 can regulate YAP1 shuttling in human epithelial cells. We therefore investigated whether PDLIM5 is expressed in HSCs and contributes to YAP1 associated HSC mechano-activation. PDLIM5 protein was detected in HSCs in fibrotic human and mouse liver. PDLIM5 transcript and protein were expressed by primary human and mouse HSCs and by the immortalised HSC LX-2 cell line. PDLIM5 localised with actin stress fibres suggesting a role in HSC adhesion. Co-immunoprecipitation and proximity ligation in LX-2 cells support an association between PDLIM5 and YAP1. We used pharmacological (paclitaxel) and genetic (siRNA and CRISPRi) approaches to inhibit PDLIM5 in HSCs. Inhibiting PDLIM5 reduced YAP1 nuclear localisation and fibrotic gene (COL1A1, ACTA2) expression in LX-2 cells. Overall, these data support a role for PDLIM5 in regulating YAP1 localisation and fibrogenic gene expression in HSCs.

cell biology↗